Mishcon de Reya page structure
Site header
Main menu
Main content section

Inside Life Sciences

Issue 10: June 2020

Inside Life Sciences

Editor's Note

Welcome to the Spring 2020 edition of Inside Life Sciences.


COVID-19 and the Life Sciences Industry

The life sciences industry has, understandably, been at the forefront of discussions regarding the global COVID-19 pandemic, with evolving pressures and challenges on governments, the healthcare system and drug developers.


High Court finds trade mark infringement through use of 'Merck'

In a long-running dispute between Merck KGaA (Merck Global) and US companies Merck Sharp & Dohme Corporation and Merck & Co (together Merck US), the High Court has decided that various uses of 'Merck' in the UK by Merck US, amount to trade mark infringement.

Mishcon de Reya interior


The Court of Justice of the European Union (the "CJEU") has given guidance on 'pay for delay' agreements for the first time in its recent decision in Generics (UK) v Competition and Markets Authority.


Patents Court considers 'clearing the way' and disclosure of launch plans

In Teva v Chiesi, the Patents Court has considered the extent to which a generic pharmaceutical company should clear the way to market before launch and the implications for an infringement counterclaim brought by a patentee based on a threat by the generic to infringe, in circumstances where the generic has not yet obtained a marketing authorisation.

Previous Issues

How can we help you?

How can we help you?

Subscribe: I'd like to keep in touch

If your enquiry is urgent please call +44 20 3321 7000

I'm a client

I'm looking for advice

Something else